Published in
American Association for the Advancement of Science, Science Translational Medicine, 622(13), 2021
DOI: 10.1126/scitranslmed.abl6851
Links
Tools
Dynamic PET-facilitated modeling and high-dose rifampin regimens for Staphylococcus aureus orthopedic implant–associated infections
Journal article published in 2021 by
Oren Gordon 
,
Donald E. Lee ,
Bessie Liu,
Brooke Langevin,
Alvaro A. Ordonez ,
Dustin A. Dikeman ,
Babar Shafiq ,
John M. Thompson ,
Paul D. Sponseller ,
Kelly Flavahan,
Martin A. Lodge ,
Steven P. Rowe ,
Robert F. Dannals ,
Camilo A. Ruiz-Bedoya ,
Timothy D. Read
and other authors.
,
Donald E. Lee ,
Bessie Liu,
Brooke Langevin,
Alvaro A. Ordonez ,
Dustin A. Dikeman ,
Babar Shafiq ,
John M. Thompson ,
Paul D. Sponseller ,
Kelly Flavahan,
Martin A. Lodge ,
Steven P. Rowe ,
Robert F. Dannals ,
Camilo A. Ruiz-Bedoya ,
Timothy D. Read
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Current rifampin dosing achieves subtherapeutic concentrations within S. aureus –infected bone, which can be overcome with higher rifampin dosing.